Purchase Short-Term Access

Review: DPP-4 inhibitors are less effective than metformin for reducing HbA_1c in type 2 diabetes

Saurav Chatterjee, MD

Annals of Internal Medicine 2012;157:JC1-13. doi:10.7326/0003-4819-157-2-201207170-02013

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)